We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Weak to moderate cytoplasmic immunoreactivity was observed in melanomas, gliomas, thyroid and prostate cancers. Hepatocellular carcinomas displayed moderate to strong positivity. Remaining cancers were weakly stained or generally negative.